BMJ 1998;316:354-360 (31 January)

General practice

Systematic review of randomised controlled trials of interventions for painful shoulder: selection criteria, outcome assessment, and efficacy

Sally Green, PhD scholar,a Rachelle Buchbinder, senior lecturer,a Richard Glazier, assistant professor,b Andrew Forbes, senior lecturer a

a Department of Epidemiology and Preventive Medicine, Monash University, Melbourne 3186, Australia, b Family and Community Medicine, Preventive Medicine and Biostatistics, University of Toronto, Ontario, Canada

Correspondence to: Dr Buchbinder rachelle.buchbinder@med.monash.edu.au


right arrow   Abstract
up arrowTop
dotAbstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences

Objective: To review the efficacy of common interventions for shoulder pain.
Design: All randomised controlled trials of non-steroidal anti-inflammatory drugs, intra-articular and subacromial glucocorticosteroid injection, oral glucocorticosteroid treatment, physiotherapy, manipulation under anaesthesia, hydrodilatation, and surgery for shoulder pain that were identified by computerised and hand searches of the literature and had a blinded assessment of outcome were included.
Main outcome measures: Methodological quality (score out of 40), selection criteria, and outcome measures. Effect sizes were calculated and combined in a pooled analysis if study population, end point, and intervention were comparable.
Results: Thirty one trials met inclusion criteria. Mean methodological quality score was 16.8 (9.5-22). Selection criteria varied widely, even for the same diagnostic label. There was no uniformity in the outcome measures used, and their measurement properties were rarely reported. Effect sizes for individual trials were small (range -1.4 to 3.0). The results of only three studies investigating "rotator cuff tendinitis" could be pooled. The only positive finding was that subacromial steroid injection is better than placebo in improving the range of abduction (weighted difference between means 35° (95% confidence interval 14 to 55)).
Conclusions: There is little evidence to support or refute the efficacy of common interventions for shoulder pain. As well as the need for further well designed clinical trials, more research is needed to establish a uniform method of defining shoulder disorders and developing outcome measures which are valid, reliable, and responsive in affected people.

Key messages

  • This systematic review found little evidence to support the use of any of the common interventions in managing shoulder pain

  • There is currently no uniformity in the way shoulder disorders are labelled or defined

  • Measurement of outcome varies widely between clinical trials and, in general, the reliability, validity, and responsiveness of these outcome measures are not established

  • Further clinical trials are needed to determine the optimal treatment strategies for shoulder pain


right arrow   Introduction
up arrowTop
up arrowAbstract
dotIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences

There are many accepted standard forms of conservative treatment for shoulder disorders, including non-steroidal anti-inflammatory drugs, corticosteroid injections, and physiotherapy, yet evidence of their efficacy is not well established. Furthermore, the interpretation of results of studies is often hampered by the fact that these disorders are labelled and defined in diverse and often conflicting ways. To determine the efficacy of common interventions for shoulder pain, we performed a systematic review of randomised controlled trials investigating these treatments. To determine whether the results of the different studies could be compared or pooled, or both, we also undertook a methodological review of the selection criteria and outcome assessment used in these studies.


right arrow   Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
dotMethods
down arrowResults
down arrowDiscussion
down arrowReferences

Identification and selection of studies
One of us (SG) searched computerised bibliographic databases (MEDLINE, EMBASE, CINAHL) without language restrictions from 1966 to September 1995 using the Cochrane Collaboration search strategy, which aims to identify all randomised controlled trials.1 This was combined with the medical subject heading "shoulder" (exploded) and other keywords pertaining to shoulder disorders or their treatment. SG also hand searched relevant conference proceedings and reviewed textbooks and reference lists of all retrieved articles.

To determine whether a study should be included, two of us (RB and RG) reviewed the retyped methods sections of all identified trials independently according to predetermined criteria (that the trial be randomised, that the outcome assessment be blinded, and that the intervention was one of those under review). Randomised controlled trials which investigated common interventions for shoulder pain in adults (age greater than or equal to 18 years) were included provided that there was a blinded assessment of outcome. For the purposes of this review, interventions were broadly categorised as non-steroidal anti-inflammatory drugs, intra-articular and subacromial glucocorticosteroid injection, oral glucocorticosteroid treatment, physiotherapy, manipulation under anaesthesia, hydrodilatation (shoulder distension), and surgery. All studies which primarily concerned pain arising from the shoulder were included irrespective of diagnostic label. Studies that included various rheumatological disorders were considered if the results on shoulder pain were presented separately or if 90% or more of patients in the study had shoulder pain.

Assessment of validity
To determine the methodological quality, RB and RG independently reviewed the retyped methods and results sections of the included studies using predetermined criteria.2 An overall score for methodological quality (out of a possible 40) was calculated to assess the overall standard of each trial, but these scores were not used to weight the pooled analysis.

Assessment of selection criteria and outcome
RB and SG reviewed the selection criteria and outcome measures. They determined whether distinct diagnoses were specified and whether definitions of these diagnoses were recorded. Inclusion and exclusion criteria were also examined. For outcome measures they recorded the types of measures used, the method of measurement, and whether the clinimetric properties had been considered. (Clinimetric or measurement properties refer to the reliability, validity, and responsiveness to change of an outcome measure, clinimetrics being the measurement of clinical phenomena.) The timing of outcome assessment was also noted.

Analysis of data
To assess efficacy, raw data (means and standard deviations) were extracted for reported outcomes when data were available in the published reports and entered into the Cochrane Collaboration’s Review Manager software program.1 For studies not reporting the required data, further details were requested of first authors, but no additional information was obtained. Range of motion scores were entered as degrees of movement, and all pain and overall effect scores were transformed to 100 point scales.

Effect sizes: individual trials
To determine the treatment effect for each end point assessed we calculated the effect size as the difference between the mean of the treatment group at follow up and the mean of the control group at follow up, divided by the pooled standard deviation:

Effect size=(xt-xc)/PSD where xt=treatment group mean, xc=control group mean, and PSD = pooled standard deviation.

In this equation, effect size is expressed as a function of standard deviation. For example, an effect size of 0.43 reflects a difference between means of 0.43 of one standard deviation.

In the five studies in which standard deviation was not reported, effect size was calculated by conversion of the reported P value to a t statistic with appropriate degrees of freedom and use of the formula


where nt=number of subjects in treatment group, nc=number of subjects in control group, and t=observed t statistic.

In the three studies which reported P values only as less than a value—for example, P<0.05, P<0.01—a conservatively small effect size was calculated as though the P value equalled the quoted value—for example, P< 0.05 was taken as P=0.05. When only the change in scores from baseline were reported (three studies), the within group standard deviation after intervention was computed assuming a (likely) conservative correlation of 0.3 between measurements before and after intervention. One study provided only the range (maximum and minimum) of scores for each group, from which the standard deviation was estimated as one quarter of the range.

After reviewing the outcomes assessed in the individual trials, we examined three end points which together provided the most detailed data: pain (100 point scale), restriction of abduction (degrees), and overall effect as reported by the patient (100 point scale).

Pooled analysis
Only trials investigating the same intervention in similar populations and using the same outcome measure at the same or similar times of follow up were considered for pooling. Pooling was carried out using the Revman 3.0 software program1 to calculate weighted difference between means, which is the difference between treatment and comparison group means at follow up, and (in contrast to effect size) is measured in the dimension of the outcome variable being combined. A random effects model was used for pooling to allow for heterogeneity between studies.3 Estimates and in particular confidence intervals from this model reduce to those from a fixed effects model when study results are homogeneous.


right arrow   Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
dotResults
down arrowDiscussion
down arrowReferences

Identification and selection of studies
Thirty one out of 58 identified studies met our selection criteria.4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 A list of excluded studies is available from us. Reasons for exclusion were lack of randomisation (23 studies), lack of blinding (12 studies), not the study population of interest (5 studies), and not the intervention of interest (6 studies). Despite blinding, 8 of the 58 trials were identified by RB or RG, or both.4 8 14 18 20 21 25 30

The included studies assessed non-steroidal anti-inflammatory drugs (17 trials),4 5 6 7 8 10 11 12 13 16 17 18 19 22 26 29 33 intra-articular or subacromial glucocorticosteroid injection (10 trials),10 11 13 14 18 23 24 25 31 32 physiotherapy (5 trials),9 15 18 20 21 oral glucocorticosteroid treatment (2 trials),31 34 hydrodilatation (2 trials),24 32 and manipulation under anaesthesia (1 trial).28 There were no randomised controlled trials of surgical interventions.

Selection criteria
Twenty four trials specified distinct diagnoses to characterise their study population. These included periarthritis (7 trials),4 5 16 27 29 30 31 adhesive capsulitis (6 trials),14 18 24 25 26 33 frozen shoulder (3 trials),28 29 31 rotator cuff tendinitis (7 trials),8 10 11 17 18 24 30 supraspinatus tendonitis (3 trials),29 30 32 bursitis (2 trials),8 14 infraspinatus tendonitis (1 trial),14 subscapularis tendonitis (1 trial),14 acromioclavicular joint sprain (1 trial),14 and rotator cuff lesion (1 trial).19 Definitions of distinct diagnoses were specified in 16 of the 24 trials. On the basis of review of the diagnostic labels or definitions of the study populations, or both, most trials could be broadly categorised as studying adhesive capsulitis (including periarthritis and frozen shoulder) (23 trials) or rotator cuff tendinitis (including supraspinatus, infraspinatus, and subscapularis tendonitis) (12 trials), or both. Six trials gave no selection criteria or population definition.6 11 21 28 30 35

The box shows the selection criteria used to define the shoulder disorders studied. In general, adhesive capsulitis was defined as the presence of pain with restriction of active and passive glenohumeral joint movements, and rotator cuff tendinitis was defined by the presence of painful arc and pain with resisted movements or a normal passive range of motion. However, no standard definitions were used, and conflicting criteria often defined the same condition in different trials. Exclusion criteria were specified in 28 studies, although these also varied widely between studies.


Selection criteria used in shoulder pain trials

Rotar cuff disease

No definition given (2 trials)

Shoulder pain and painful arc (1 trial)

At least two of painful abduction, painful arc, and tenderness of supraspinatus insertion (1 trial)

Painful arc between 40° and 120° abduction (1 trial)

Pain on resisted abduction, tenderness over supraspinatus tendon, and normal passive motion (1 trial)

Pain with resistance in abduction and external and internal rotation (1 trial)

Pain with resisted movements of the shoulder and loss of passive abduction (1 trial)

Pain on resisted abduction with or without resisted external rotation (1 trial)

Pain exacerbated by resisted movement, passive range > active range, normal passive range (1 trial)

Full range of passive motion and pain on resisted abduction (1 trial)

Adhesive capsulitis

No definition given (8 trials)

External rotation <30° and abduction < 90° (1 trial)

Total passive movement <50% of normal with pain worse at night (1 trial)

Generalised limitation of glenohumeral motion with pain at rest or on movement (5 trials)

Pain, active and passive motion limited to >20°, pain on resisted abduction or rotation, and impaired glenohumeral joint (1 trial)

Loss of passive motion of glenohumeral joint (1 trial)

Pain, restriction of movement, loss of full function, and pain at night with inability to lie on affected side (1 trial)

Pain at night, inability to lie on affected side, restriction of active and passive motion, restriction of external rotation (2 trials)

Restriction of abduction and external rotation (1 trial)

Appreciable restriction of both active and passive motion (1 trial)

Abduction and flexion <90° and external rotation <20° (1 trial)

Abduction and flexion <70% and external rotation <20% (1 trial)

Assessment of outcome
Table 1 summarises the outcomes assessed. Pain and range of motion were recorded in most trials (29 and 27 respectively). Only four studies included an adequate description of how range of motion was assessed (measurement tool and definition of end of range).16 21 22 35 Function was assessed in eight studies and was measured either by visual analogue scale14 15 16 17 18 19 26 or return to work.20 No study included a disability index. Although two studies cited a reliability study for their method of range of motion assessment,21 35 no other reference was made to the reliability, validity, or responsiveness of the outcome measures used. Timing of assessment for the primary efficacy analysis varied between 1 and 24 weeks.


 
View this table:
[in this window]
[in a new window]
 
Table 1 Outcome measures used in 31 trials of intervention for shoulder pain and stiffness

Validity of individual trials
Table 2 shows the overall scores for the quality of methods and for each category for each trial. The mean quality score of all trials combined was 16.8 out of a possible 40 points (42%). No trial scored greater than 22 out of a possible score of 40 (range 9.5-22.0).


 
View this table:
[in this window]
[in a new window]
 
Table 2 Summary of validity scores and effect sizes for overall pain, restriction in abduction, and overall efficacy for all included studies

Individual trials
Table 2 shows effect sizes according to intervention. In general, the effect sizes were small, suggesting a lack of clear benefit for any of the treatments investigated.

Pooled analysis
Most results of individual trials could not be pooled because of a lack of similarity of study population, outcome measures, timing of outcome assessment, or insufficient reported data. Pooling of results was performed for two studies of non-steroidal anti-inflammatory drugs and placebo in rotator cuff tendinitis (table 3).10 11 The weighted difference between means suggested that non-steroidal anti-inflammatory drugs may be superior to placebo in improving the degree of restriction of abduction (26 degrees (95% confidence interval -9 to 61)). The weighted difference between means for pain score was 3 (-19 to 25). Data from the same two trials were pooled to determine the efficacy of subacromial steroid injection and placebo in rotator cuff tendinitis (table 3).10 11 The weighted difference between means suggested injection was superior to placebo in improving range of abduction (35 (14 to 55)).


 
View this table:
[in this window]
[in a new window]
 
Table 3 Pooled analyses. Values are weighted differences between means (95% confidence intervals)

Pooling of results was also performed for two studies which compared non-steroidal anti-inflammatory drugs and steroid injection with non-steroidal anti-inflammatory drugs alone in rotator cuff tendinitis (table 3).10 18 The weighted difference between means showed no added benefit of injection with respect to both restriction of abduction (4 (-14 to 22 )) and pain (-2 (-11 to 7 )).


right arrow   Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
dotDiscussion
down arrowReferences

This review has confirmed the lack of uniformity in the way shoulder disorders are labelled and defined. It has also highlighted the wide variation in assessment of outcome in clinical trials investigating the efficacy of interventions for painful shoulder. These factors limit the degree to which the results of different trials can be compared and pooled. In addition, the heterogeneity of the interventions studied, the timing of outcome assessment, the overall poor methodological quality, inadequate reporting of results, and small sample sizes preclude the drawing of firm conclusions about the efficacy of any of the interventions studied.

On the basis of our review, the only conclusions that may be drawn about efficacy are that non-steroidal anti-inflammatory drugs and subacromial glucocorticosteroid injection may be superior to placebo in improving range of abduction in rotator cuff tendinitis and that the addition of corticosteroid injection to non-steroidal anti-inflammatory drugs does not seem to confer further benefit. These pooled results should be interpreted cautiously. In addition to the above concerns, statistical manipulation of inadequately presented results was necessary to perform these analyses. No conclusions can be drawn about the efficacy of the interventions studied for adhesive capsulitis.

Previous reviews
Previous separate reviews of non-steroidal anti-inflammatory drugs, steroid injections, and physiotherapy have been performed by investigators in the Netherlands.35 36 37 Although our study confirms their conclusions on the poor overall methodological quality of reviewed trials, our study differs in several important respects.

Firstly, we tried to differentiate studies on the basis of the nature of the populations being studied, recognising that the benefits of treatment may vary for different underlying causes of shoulder pain.

Secondly, we calculated effect sizes for the same reported outcome measures in different trials. This enables a direct comparison between studies using the same outcome measurement, although it is important to note that if one effect size is larger than another it may be because in the different studies the numerator (the treatment effect) is larger, the denominator (the variability between subjects in each group) is smaller, or there is some combination of the two. In the previous reviews the overall efficacy of interventions was described by calculation of success rates for each intervention group. These were determined by dividing the number of documented successes (defined as recovery or substantial improvement from baseline, according to the patient) at the end of the intervention period by the number allocated to the intervention by randomisation. The exact definition of success therefore differed between papers and is, in essence, subjective.36

Finally, we performed a detailed assessment of the outcome measures used in previous trials. While most studies incorporated a measure of pain and range of motion, the accompanying disability, which may be of utmost importance to the patient and therefore a more appropriate end point, was neglected in most studies. Furthermore, the reliability and responsiveness of the outcome measures used in most trials has not been established. To improve our ability to interpret and compare the results of different studies, further work is needed to address these issues.

Another recent systematic review of corticosteroid injection for rotator cuff tendinitis concluded that steroid injection is effective in treating it.38 However, this conclusion cannot be verified by our results. The other review included non-randomised studies, the results of primary studies were reported only as significant or not significant, and no attempt was made to measure effect sizes or pool results.

Further research
Systematic reviews of randomised controlled trials serve to identify parts of clinical practice where further research is required. We could not draw firm conclusions about the efficacy of any of the common interventions currently being used to treat painful shoulders from this review. Therefore further clinical trials are needed to justify or censure current treatment strategies. These trials should carefully consider their study population and measures of outcome. Adoption of a uniform method of labelling and defining shoulder disorders and incorporation of a standard set of outcome measures may greatly enhance these efforts. This review will be updated through the Musculoskeletal Review Group of the Cochrane Collaboration as further trials are performed.


right arrow   Acknowledgements

We thank the Australasian Cochrane Centre and the Musculoskeletal Cochrane Review Group for their methodological support.

Funding: None.

Conflict of interest: None.


right arrow   Notes

Contributors: RB initiated and lodged the protocol for the project with the Cochrane Collaboration. SG coordinated the project under RB’s supervision. SG searched the literature, retrieved data, and performed blinding. RB and RG performed the methodological review and determined inclusion. SG entered and synthesised the data and analysed and interpreted the results. AF, RG, and RB also analysed and interpreted the results. All authors wrote the paper. RB is the guarantor for the study.


right arrow   References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
dotReferences

  1. Oxman A, ed. Preparing and maintaining systematic reviews. In Cochrane Collaboration handbook. Oxford: Cohrane Collaboration, 1994.
  2. Glazier R, Buchbinder R, Bell M. Critical appraisal of continuing medical education in the rheumatic diseases for primary care physicians. Arthritis Rheum 1995;38:533-8. [Medline]
  3. Dersimmion R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986;7:177-88. [Medline]
  4. Thumb N, Kolarz G, Scherak O, Mayrhofer F. The efficacy and safety of fentiazac and diclofenac sodium in periarthritis of the shoulder: a multicenter, double-blind comparison. J Int Med Res 1987;15:327-34. [Medline]
  5. Huskisson EC, Bryans R. Diclofenac sodium in the treatment of painful stiff shoulder. Curr Med Res Opin 1983;8:350-3. [Medline]
  6. Friis J, Jarner D, Toft B, Christense K, Christophersen J, Ibfelt H, et al. Comparison of two ibuprofen formulations in the treatment of shoulder tendonitis. Clin Rheumatol 1992;11:105-8. [Medline]
  7. Yamamoto M, Sugano T, Kashiwazaki T, Kageyama T, Mizushima Y, Kameyama M. Double blind comparison of piroxicam and indomethacin in the treatment of cervicobrachial syndrome and periarthritis scapulohumeralis (stiff shoulder). Eur J Rheum Inflamm 1983;6:266-73.
  8. White RH, Paull DM, Fleming KW. Rotator cuff tendonitis: comparison of subacromial injection of a long acting corticosteroid versus oral indomethacin therapy. J Rheumatol 1986;13:608-13. [Medline]
  9. Nicholson G. The effects of passive joint mobilisation on pain and hypomobility associated with adhesive capsulitis of the shoulder. J Orthop Sports Physiother 1985;6:238-46.
  10. Petri M, Dobrow R, Neiman R, Whiting-O’Keefe Q, Seamen WE. Randomised, double-blind, placebo-controlled study of the treatment of the painful shoulder. Arthritis Rheum 1987;30:1040-5. [Medline]
  11. Adebajo A, Nash P, Hazleman BL. A prospective double blind dummy placebo controlled study comparing triamcinolone hexacetonide injection with oral diclofenac 50 mg TDS in patients with rotator cuff tendonitis. J Rheumatol 1990;7:1207-10.
  12. Cohen A, Cohen RW. Short term treatment of acute bursitis of the shoulder. Pa Med 1968;1:66-70.
  13. Hollingworth GR, Ellis RM, Hattersley TS. Comparison of injection techniques for shoulder pain: results of a double blind, randomised study. BMJ 1983;287:1339-41.
  14. Withrington RH, Girgis FL, Seifert MH. A placebo-controlled trial of steroid injections in the treatment of supraspinatus tendonitis. Scand J Rheumatol 1985;14:76-8. [Medline]
  15. Leclaire R, Bourgouin J. Electromagnetic treatment of shoulder periarthritis: a randomised controlled trial of the efficiency and tolerance of magnotherapy. Arch Phys Med Rehabil 1991;72:284-7. [Medline]
  16. Wielandts L, Dequeker J. Double-blind trial comparing fentiazac with phenylbutazone in patients with tendinitis. Curr Med Res Opin 1979;6(suppl 2):85-9.
  17. Duke O, Zecler E, Grahame R. Anti-inflammatory drugs in periarthritis of the shoulder: a double-blind, between-patient, study of naproxen versus indomethacin. Rheum Rehabil 1981;20:54-9.
  18. Berry H, Fernandes L, Bloom B, Clark RJ, Hamilton EBD. Clinical study comparing acupuncture, physiotherapy, injection and oral anti-inflammatory therapy in shoulder-cuff lesions. Curr Med Res Opin 1980;7:121-6. [Medline]
  19. Ginsberg F, Famaey JP. A double-blind comparison of slow-release and standard tablet formulations of fentiazac in the treatment of patients with tendonitis and bursitis. Curr Med Res Opin 1985;9:442-8. [Medline]
  20. Binder A, Parr G, Hazleman B, Fitton-Jackson S. Pulsed electromagnetic field therapy of persistent rotator cuff tendonitis. Lancet 1984;323:695-8.
  21. England S, Farrell AJ, Coppock JS, Struthers G, Bacon PA. Low power laser therapy of shoulder tendonitis. Scand J Rheumatol 1989;18:427-31. [Medline]
  22. Smith MD, Thomas D, McCredie M, Brooks PM. Piroxicam versus naproxen in the treatment of painful shoulder. Pharm 1986;4:585-9.
  23. Richardson AT. The painful shoulder. Proc R Soc Med 1975;68:11-6.
  24. Corbeil V, Dussault RG, Leduc BE, Fleury J. Capsulite retractile de l’epaule: etude comparative de l’arthrographie avec corticotherapie intra-articulaire avec ou sans distension capsulaire. J Can Assoc Radiol 1992;43:127-30.
  25. Rizk TE, Pinals RS, Talaiverm AS. Corticosteroid injections in adhesive capsulitis: investigation of their value and site. Arch Phys Med Rehabil 1991;72:20-2. [Medline]
  26. Ward MC, Kirwan JR, Norris P, Murray N. Paracetamol and diclofenac in the painful shoulder syndrome. Br J Rheumatol 1986;25:412-20.
  27. Gotter G. Comparative evaluation of tenoxicam and piroxicam in the treatment of humeroscapular periarthritis. Eur J Rheum Inflamm 1987;9:95-7.
  28. Thomas D, Williams RA, Smith DS. The frozen shoulder: a review of manipulative treatment. Rheum Rehabil 1980;19:173-9.
  29. Famaey JP, Ginsberg F. Treatment of periarthritis of the shoulder: a comparison of ibuprofen and diclofenac. J Int Med Res 1984;12:238-43. [Medline]
  30. Blockey NJ, Wright JK, Kellgren JH. Oral cortisone therapy in periarthritis of the shoulder. BMJ 1954;1:1455-7.
  31. Bulgen DY, Binder AI, Hazleman BL, Dutton J, Roberts S. Frozen shoulder: prospective clinical study with an evaluation of three treatment regimes. Ann Rheum Dis 1984;43:353-60. [Abstract/Free Full Text]
  32. Jacobs LGH, Barton MAJ, Wallace WA, Ferrousis J, Dunn NA, Bossingham DH. Intra-articular distension and steroids in the management of capsulitis of the shoulder. BMJ 1991;302:1498-501.
  33. Rhind V, Downie WW, Bird HA, Wright V, Engler C. Naproxen and indomethacin in periarthritis of the shoulder. Rheum Rehabil 1982;21:51-3.
  34. Binder A, Hazleman BL, Parr G, Roberts S. A controlled study of oral prednisolone in frozen shoulder. Br J Rheumatol 1986;25:288-92. [Abstract/Free Full Text]
  35. Van der Windt DAWM, van der Heijden GJMG, Scholten RJPM, Koes BW, Bouter LM. The efficacy of non-steroidal anti-inflammatory drugs (NSAIDS) for shoulder complaints. A systematic review. J Clin Epidemiol 1995;48:691-704. [Medline]
  36. Van der Heijden GJMG, van der Windt DAWM, de Winter SF. Physiotherapy for patients with soft tissue shoulder disorders: a systematic review of randomised clinical trials. BMJ 1997;315:25-30. [Abstract/Free Full Text]
  37. Van der Heijden GJMG, van der Windt DAWM, Kleijnen J, Koes B, Bouter L. Steroid injections for shoulder disorders: a systematic review of randomised clinical trials. Br J Gen Pract 1996;46:309-16. [Medline]
  38. Goupille P, Sibillia J. Local corticosteroid injections in the treatment of rotator cuff tendinitis (except for frozen shoulder and calcific tendinitis). Clin Exp Rheumatol 1996;14:561-6. [Medline]
(Accepted 23 September 1997)


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Radial extracorporeal shockwave treatment compared with supervised exercises in patients with subacromial pain syndrome: single blind randomised study
Kaia Engebretsen, Margreth Grotle, Erik Bautz-Holter, Leiv Sandvik, Niels G Juel, Ole Marius Ekeberg, and Jens Ivar Brox
BMJ 2009 339: b3360. [Abstract] [Full Text] [PDF]

Shoulder pain: diagnosis and management in primary care
Caroline Mitchell, Ade Adebajo, Elaine Hay, and Andrew Carr
BMJ 2005 331: 1124-1128. [Extract] [Full Text] [PDF]

Interventions to treat shoulder pain
Bela Szebenyi, Paul Dieppe, Andrew Bamji, Rachelle Buchbinder, Sally Green, Andrew Forbes, and Richard Glazier
BMJ 1998 316: 1676. [Extract] [Full Text]

This article has been cited by other articles:

  • Engebretsen, K., Grotle, M., Bautz-Holter, E., Sandvik, L., Juel, N. G, Ekeberg, O. M., Brox, J. I. (2009). Radial extracorporeal shockwave treatment compared with supervised exercises in patients with subacromial pain syndrome: single blind randomised study. BMJ 339: b3360-b3360 [Abstract] [Full text]  
  • McKenna, C., Bojke, L., Manca, A., Adebajo, A., Dickson, J., Helliwell, P., Morton, V., Russell, I., Torgerson, D., Watson, J. (2009). Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis. Rheumatology (Oxford) 48: 558-563 [Abstract] [Full text]  
  • Vavken, P., Holinka, J., Rompe, J. D., Dorotka, R. (2009). Focused Extracorporeal Shock Wave Therapy in Calcifying Tendinitis of the Shoulder: A Meta-Analysis. Sports Health: A Multidisciplinary Approach 1: 137-144 [Abstract] [Full text]  
  • Watson, J., Helliwell, P., Morton, V., Adebajo, A., Dickson, J., Russell, I., Torgerson, D. (2008). Shoulder acute pain in primary healthcare: is retraining effective for GP principals? SAPPHIRE--a randomized controlled trial. Rheumatology (Oxford) 47: 1795-1802 [Abstract] [Full text]  
  • Bal, A., Eksioglu, E., Gulec, B., Aydog, E., Gurcay, E., Cakci, A. (2008). Effectiveness of corticosteroid injection in adhesive capsulitis. Clin Rehabil 22: 503-512 [Abstract]  
  • Ainsworth, R., Dziedzic, K., Hiller, L., Daniels, J., Bruton, A., Broadfield, J. (2007). A prospective double blind placebo-controlled randomized trial of ultrasound in the physiotherapy treatment of shoulder pain. Rheumatology (Oxford) 46: 815-820 [Abstract] [Full text]  
  • Albert, J.-D., Meadeb, J., Guggenbuhl, P., Marin, F., Benkalfate, T., Thomazeau, H., Chales, G. (2007). High-energy extracorporeal shock-wave therapy for calcifying tendinitis of the rotator cuff: A RANDOMISED TRIAL. J Bone Joint Surg Br 89-B: 335-341 [Abstract] [Full text]  
  • Watson, L., Bialocerkowski, A., Dalziel, R., Balster, S., Burke, F., Finch, C. (2007). Hydrodilatation (distension arthrography): a long-term clinical outcome series. Br. J. Sports. Med. 41: 167-173 [Abstract] [Full text]  
  • Koester, M. C., Dunn, W. R., Kuhn, J. E., Spindler, K. P. (2007). The Efficacy of Subacromial Corticosteroid Injection in the Treatment of Rotator Cuff Disease: A Systematic Review. J Am Acad Orthop Surg 15: 3-11 [Abstract] [Full text]  
  • Giombini, A., Di Cesare, A., Safran, M. R., Ciatti, R., Maffulli, N. (2006). Short-term Effectiveness of Hyperthermia for Supraspinatus Tendinopathy in Athletes: A Short-term Randomized Controlled Study. Am J Sports Med 34: 1247-1253 [Abstract] [Full text]  
  • van Meeteren, J, Roebroeck, M E, Selles, R W, Stam, H J (2006). Responsiveness of isokinetic dynamometry parameters, pain and activity level scores to evaluate changes in patients with capsulitis of the shoulder. Clin Rehabil 20: 496-501 [Abstract]  
  • Cacchio, A., Paoloni, M., Barile, A., Don, R., de Paulis, F., Calvisi, V., Ranavolo, A., Frascarelli, M., Santilli, V., Spacca, G. (2006). Effectiveness of Radial Shock-Wave Therapy for Calcific Tendinitis of the Shoulder: Single-Blind, Randomized Clinical Study. ptjournal 86: 672-682 [Abstract] [Full text]  
  • Mitchell, C., Adebajo, A., Hay, E., Carr, A. (2005). Shoulder pain: diagnosis and management in primary care. BMJ 331: 1124-1128 [Full text]  
  • Johansson, K. M, Adolfsson, L. E, Foldevi, M. O. (2005). Effects of Acupuncture Versus Ultrasound in Patients With Impingement Syndrome: Randomized Clinical Trial. ptjournal 85: 490-501 [Abstract] [Full text]  
  • Paoloni, J. A., Appleyard, R. C., Nelson, J., Murrell, G. A. C. (2005). Topical Glyceryl Trinitrate Application in the Treatment of Chronic Supraspinatus Tendinopathy: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Am J Sports Med 33: 806-813 [Abstract] [Full text]  
  • Champion, G, Buchbinder, R, Green, S, Hall, S, Nash, P, Forbes, A, Hoving, J L (2005). Frozen shoulder * Authors' reply. Ann Rheum Dis 64: 795-796 [Full text]  
  • Ryans, I., Montgomery, A., Galway, R., Kernohan, W. G., McKane, R. (2005). A randomized controlled trial of intra-articular triamcinolone and/or physiotherapy in shoulder capsulitis. Rheumatology (Oxford) 44: 529-535 [Abstract] [Full text]  
  • Buchbinder, R, Hoving, J L, Green, S, Hall, S, Forbes, A, Nash, P (2004). Short course prednisolone for adhesive capsulitis (frozen shoulder or stiff painful shoulder): a randomised, double blind, placebo controlled trial. Ann Rheum Dis 63: 1460-1469 [Abstract] [Full text]  
  • Paul, A, Lewis, M, Shadforth, M F, Croft, P R, van der Windt, D A W M, Hay, E M (2004). A comparison of four shoulder-specific questionnaires in primary care. Ann Rheum Dis 63: 1293-1299 [Abstract] [Full text]  
  • Buchbinder, R, Green, S (2004). Effect of arthrographic shoulder joint distension with saline and corticosteroid for adhesive capsulitis. Br. J. Sports. Med. 38: 384-385 [Full text]  
  • Buchbinder, R, Green, S, Forbes, A, Hall, S, Lawler, G (2004). Arthrographic joint distension with saline and steroid improves function and reduces pain in patients with painful stiff shoulder: results of a randomised, double blind, placebo controlled trial. Ann Rheum Dis 63: 302-309 [Abstract] [Full text]  
  • Kassimos, D G, Panayi, G, van der Windt, D A W M (2004). Differences in the management of shoulder pain between primary and secondary care in Europe: time for a consensus * Author's reply. Ann Rheum Dis 63: 111-112 [Full text]  
  • Gerdesmeyer, L., Wagenpfeil, S., Haake, M., Maier, M., Loew, M., Wortler, K., Lampe, R., Seil, R., Handle, G., Gassel, S., Rompe, J. D. (2003). Extracorporeal Shock Wave Therapy for the Treatment of Chronic Calcifying Tendonitis of the Rotator Cuff: A Randomized Controlled Trial. JAMA 290: 2573-2580 [Abstract] [Full text]  
  • McInerney, J J, Dias, J, Durham, S, Evans, A (2003). Randomised controlled trial of single, subacromial injection of methylprednisolone in patients with persistent, post-traumatic impingment of the shoulder. Emerg. Med. J. 20: 218-221 [Abstract] [Full text]  
  • van der Windt, D A W M, Bouter, L M (2003). Physiotherapy or corticosteroid injection for shoulder pain?. Ann Rheum Dis 62: 385-387 [Full text]  
  • Hay, E M, Thomas, E, Paterson, S M, Dziedzic, K, Croft, P R (2003). A pragmatic randomised controlled trial of local corticosteroid injection and physiotherapy for the treatment of new episodes of unilateral shoulder pain in primary care. Ann Rheum Dis 62: 394-399 [Abstract] [Full text]  
  • Shanahan, E M, Ahern, M, Smith, M, Wetherall, M, Bresnihan, B, FitzGerald, O (2003). Suprascapular nerve block (using bupivacaine and methylprednisolone acetate) in chronic shoulder pain. Ann Rheum Dis 62: 400-406 [Abstract] [Full text]  
  • Norregaard, J, Krogsgaard, M R, Lorenzen, T, Jensen, E M (2002). Diagnosing patients with longstanding shoulder joint pain. Ann Rheum Dis 61: 646-649 [Abstract] [Full text]  
  • Turner-Stokes, L., Jackson, D. (2002). Shoulder pain after stroke: a review of the evidence base to inform the development of an integrated care pathway. Clin Rehabil 16: 276-298 [Abstract]  
  • Speed, C. A. (2001). Therapeutic ultrasound in soft tissue lesions. Rheumatology (Oxford) 40: 1331-1336 [Abstract] [Full text]  
  • Philadelphia Panel Members, , Clinical Specialty Experts, , Albright, J., Allman, R., Bonfiglio, R. P., Conill, A., Dobkin, B., Guccione, A. A, Hasson, S., Russo, R., Shekelle, P., Susman, J. L, Ottawa Methods Group, , Brosseau, L., Tugwell, P., Wells, G. A, Robinson, V. A, Graham, I. D, Shea, B. J, McGowan, J., Peterson, J., Corriveau, H., Morin, M., Pelland, L., Poulin, L., Tousignant, M., Laferriere, L., Casimiro, L., Tremblay, L. E (2001). Philadelphia Panel Evidence-Based Clinical Practice Guidelines on Selected Rehabilitation Interventions for Shoulder Pain. ptjournal 81: 1719-1730 [Abstract] [Full text]  
  • Roddey, T. S, Olson, S. L, Cook, K. F, Gartsman, G. M, Hanten, W. (2000). Comparison of the University of California-Los Angeles Shoulder Scale and the Simple Shoulder Test With the Shoulder Pain and Disability Index: Single-Administration Reliability and Validity. ptjournal 80: 759-768 [Abstract] [Full text]  
  • van der Heijden, G. J M G, Leffers, P., Wolters, P. J M C, Verheijden, J. J D, van Mameren, H., Houben, J. P, Bouter, L. M, Knipschild, P. G (1999). No effect of bipolar interferential electrotherapy and pulsed ultrasound for soft tissue shoulder disorders: a randomised controlled trial. Ann Rheum Dis 58: 530-540 [Abstract] [Full text]  
  • Ebenbichler, G. R., Erdogmus, C. B., Resch, K. L., Funovics, M. A., Kainberger, F., Barisani, G., Aringer, M., Nicolakis, P., Wiesinger, G. F., Baghestanian, M., Preisinger, E., Fialka-Moser, V., Weinstabl, R. (1999). Ultrasound Therapy for Calcific Tendinitis of the Shoulder. NEJM 340: 1533-1538 [Abstract] [Full text]  
  • de Winter, A. F, Jans, M. P, Scholten, R. J P M, Devillé, W., van Schaardenburg, D., Bouter, L. M (1999). Diagnostic classification of shoulder disorders: interobserver agreement and determinants of disagreement. Ann Rheum Dis 58: 272-277 [Abstract] [Full text]  
  • van der Windt, D A W M, Koes, B W, Devillé, W, Boeke, A J P, de Jong, B A, Bouter, L M (1998). Effectiveness of corticosteroid injections versus physiotherapy for treatment of painful stiff shoulder in primary care: randomised trial. BMJ 317: 1292-1296 [Abstract] [Full text]  
  • Szebenyi, B., Dieppe, P., Bamji, A., Buchbinder, R., Green, S., Forbes, A., Glazier, R. (1998). Interventions to treat shoulder pain. BMJ 316: 1676a-1676 [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ